Effects of renal denervation on insulin resistance

Area of Science:

• Cardiovascular Medicine
• Metabolic Disorders
• Interventional Cardiology

Background:

• Hypertension and diabetes are leading causes of cardiovascular disease.
• Optimal control of blood pressure and glucose remains challenging despite available therapies.
• Sympathetic nervous system overactivity contributes to hypertension and related comorbidities.

Purpose of the Study:

• To evaluate the role of catheter-based sympathetic renal denervation (RDN) in managing treatment-resistant hypertension.
• To explore the potential impact of RDN on glucose metabolism, including fasting glucose, insulin levels, and HOMA index.
• To assess RDN as a therapeutic option for patients with resistant hypertension and altered glucose metabolism.

Main Methods:

• Catheter-based sympathetic renal denervation (RDN) procedure.
• Monitoring of blood pressure control.
• Assessment of glycemic control parameters: fasting glucose, insulin levels, and Homeostasis Model Assessment (HOMA) index.

Main Results:

• RDN has emerged as a significant treatment for resistant hypertension.
• Preliminary data suggest RDN may improve blood pressure control.
• Early findings indicate potential reductions in fasting glucose and insulin, and improved HOMA index.

Conclusions:

• RDN is a promising intervention for resistant hypertension.
• RDN may offer benefits for glycemic control in patients with coexisting hypertension and diabetes.
• Further large-scale controlled trials are needed to confirm these findings and establish RDN as a preferred treatment.